Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach

Por um escritor misterioso
Last updated 22 outubro 2024
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Toxics, Free Full-Text
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages - ScienceDirect
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Toxics, Free Full-Text
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
8. Adverse Outcome Pathways — ComptoxAI 0.1a documentation
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
PDF) Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Identification of toxicity pathway of diesel particulate matter using AOP of PPARγ inactivation leading to pulmonary fibrosis - ScienceDirect
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Toxics, Free Full-Text
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Sprague Dawley rats were injected with lentiviral particles carrying
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
AOP for PPARγ inactivation leading to fibrosis. MIE is an inactivation
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Full article: Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities. - Abstract - Europe PMC

© 2014-2024 fluidbit.co.ke. All rights reserved.